封面
市场调查报告书
商品编码
1553431

首页 睡眠呼吸中止症测试市场规模、份额、趋势分析报告:按地区、细分市场预测,2024-2030 年

Home Sleep Apnea Test Market Size, Share & Trends Analysis Report By Region (North America, Asia Pacific, Europe, Latin America, Middle East & Africa), And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

家庭睡眠呼吸中止症测试市场的成长与趋势:

Grand View Research, Inc.最新报告显示,预计2030年全球家庭睡眠呼吸中止症检测市场规模将达33.8亿美元,2024年至2030年复合年增长率为6.4%。

市场成长是由知名公司不断增加投资推动的,这些投资旨在推动家庭睡眠呼吸中止症测试 (HSAT) 的技术进步。例如,2024年3月,倍灵科技有限公司启动了评估倍灵环平台的临床试验。 Belun Ring 是一种可穿戴技术,采用人工智慧 (AI) 协助医疗专业人员诊断阻塞型睡眠呼吸中止症(OSA) 并对睡眠阶段进行分类。对于家用睡眠评估,请使用这种环形设备,该设备具有内建脉动式血氧监测仪系统和加速计,并佩戴在近端食指上。

此外,睡眠呼吸中止症的盛行率不断上升,以及旨在提高人们对治疗睡眠呼吸中止症的技术先进解决方案的认识的倡议不断增多,也推动了市场的成长。根据美国国家老化委员会 2024 年 5 月发布的资料,大约有 600 万美国被正式诊断出患有睡眠呼吸暂停,但这种情况估计影响了美国 3,000 万人。睡眠呼吸中止症的盛行率往往会随着年龄的增长而增加,研究显示 65 岁以上的成年人患阻塞型睡眠呼吸中止症的风险增加 56%。

COVID-19 透过鼓励最终用户采用远端医疗解决方案对市场产生了积极影响。根据 Itamar Medical 与 Sleep Medicine Publication 合作进行的 2021 年 3 月调查显示,29% 的睡眠诊所优先考虑实验室测试而不是家用解决方案,而且这一比例预计会进一步下降。这一转变得到了一次性家庭睡眠呼吸中止测试 (HSAT) 的采用的支持,该测试不需要退货运输或设备隔离。居家呼吸暂停测试提供即时结果的能力增强,进一步减少了对传统实验室测试指导患者从初始筛检到诊断和治疗的依赖。在大流行期间,67% 的诊所报告说,实验室中的患者检测数量中度至显着减少,而 66% 的诊所则指出,家庭睡眠呼吸中止症检测的使用量也出现了类似的增加。 65% 的诊所预测这一趋势将在新冠疫情后持续下去,他们更倾向于将 HSAT 作为睡眠呼吸中止症的主要诊断工具。

此外,市场主要企业正在采取併购、合作、联盟、业务扩张和新产品发布等各种策略,以满足最终用户不断变化的需求并巩固其市场地位。例如,2023 年 3 月,英国医疗技术公司 Acurable 在美国推出了用于阻塞型睡眠呼吸中止症诊断的 AcuPebble 设备,继最近获得 FDA核准后扩大了其市场范围。该设备于 2021 年首次在欧洲推出,增强了偏远地区的家庭睡眠呼吸中止症测试能力,有助于更快诊断、加速治疗和更好地管理病情。

首页 睡眠呼吸中止测试市场报告亮点

  • 2023 年,北美市场占有率最大,达 47.74%。呼吸系统疾病盛行率上升、阻塞型睡眠呼吸中止症(OSA)意识增强以及支持市场成长的政府支持政策推动了市场成长。
  • 预计2024年至2030年,亚太市场将以8.0%的复合年增长率成长最快。这一增长归功于该地区大量采用技术先进的 HSAT。
  • 主要企业正在采取各种策略,例如产品发布、联盟、收购和合併,以扩大其服务组合併加强其地理影响力,从而导致市场内的激烈竞争。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 家庭睡眠呼吸中止症测试市场变数、趋势与范围

  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
  • 家用睡眠呼吸中止症测试市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第 4 章 家庭睡眠呼吸中止症测试市场:区域估计和趋势分析,按产品、按应用、按最终用途

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模、预测趋势分析:
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第五章竞争状况

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 2023年主要企业市场占有率/地位分析
  • 公司简介
    • Resmed
    • Itamar Medical Ltd a subsidiary of ZOLL Medical Corporation(a ASAHI KASEI company)
    • Cleveland Medical Devices Inc.
    • Compumedics Limited
    • Onera Technologies BV
    • Sunrise
    • Nox Medical
    • Watermark Medical
    • Bittium
    • Cadwell Industries Inc.
Product Code: GVR-4-68040-412-3

Home Sleep Apnea Test Market Growth & Trends:

The global home sleep apnea test market size is expected to reach USD 3.38 billion by 2030, growing at a CAGR of 6.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is attributed to the increasing investment by prominent players, aimed at technological advancements in the home sleep apnea tests (HSAT). For instance, in March 2024, Belun Technology Company Ltd. launched a clinical trial aimed at the evaluation of the Belun Ring platform. The Belun Ring, a wearable technology, employs Artificial Intelligence (AI) to assist medical professionals in diagnosing Obstructive Sleep Apnea (OSA) and categorizing sleep phases. For home sleep assessments, individuals use this ring device, which incorporates a pulse oximeter and an accelerometer and is worn on the proximal index finger.

Moreover, the increasing prevalence of sleep apnea coupled with growing initiatives aimed at increasing awareness regarding the availability of technologically advanced solutions to treat sleep apnea is also contributing to the market growth. According to data published by the National Council on Aging, Inc. in May 2024 showcases that approximately 6 million Americans are formally diagnosed with sleep apnea; however, the condition is estimated to impact 30 million people within the U.S. The prevalence of sleep apnea tends to increase with age, the studies indicate that adults aged 65 and above exhibit a 56% higher risk of developing obstructive sleep apnea.

COVID-19 positively impacted the market as it forced the end users to adopt remote medical solutions. According to a survey conducted by Itamar Medical in partnership with Sleep Medicine Publication in March 2021 showcased that 29% of sleep clinics prioritize in-lab studies over at-home solutions-a proportion anticipated to decline further. This shift is supported by the adoption of disposable Home Sleep Apnea Tests (HSATs), which prevent the need for return shipping or equipment quarantine. Enhanced capabilities of home-based apnea tests, delivering instant results, further reduce the dependency on traditional in-lab studies for patient progression from initial screening through to diagnosis and treatment. During the pandemic, 67% of the clinics reported a moderate to significant reduction in in-lab patient studies, whereas 66% noted a comparable increase in the utilization of home sleep apnea tests. A substantial 65% of clinics foresee the continuation of this trend post-COVID, with a preference for HSATs as the primary diagnostic tool for sleep apnea.

Furthermore, key players in the market are adopting various strategies such as mergers & acquisitions, partnerships, collaborations, expansions, and new product launches to cater to the evolving demand of end users and strengthen their market positions. For instance, in March 2023, UK-based medical technology firm Acurable expanded its market reach by launching the AcuPebble device for the diagnosis of obstructive sleep apnea in the U.S. following recent FDA approval. Initially introduced in Europe in 2021, this device enhances the capability for remote, home-based sleep apnea testing, facilitating prompt diagnosis, accelerated treatment, and improved management of the condition.

Home Sleep Apnea Test Market Report Highlights:

  • North America held the largest market share of 47.74% in 2023. The market growth is attributed to a rising incidence of respiratory conditions, enhanced recognition of Obstructive Sleep Apnea (OSA), and supportive government policies that are fueling the market growth.
  • The market in Asia Pacific is expected to register the fastest growth rate at a CAGR of 8.0% from 2024 to 2030. The growth is attributed to the significant adoption of technologically advanced HSATs in the region.
  • Major players are employing various strategies such as product launches, collaborations, acquisitions, and mergers to expand their service portfolios and enhance their geographical presence, leading to significant competition within the market.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional scope
    • 1.1.2. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Home Sleep Apnea Test Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
    • 3.1.2. Market restraint analysis
    • 3.1.3. Market Opportunity Analysis
  • 3.2. Home Sleep Apnea Test Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier power
      • 3.2.1.2. Buyer power
      • 3.2.1.3. Substitution threat
      • 3.2.1.4. Threat of new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental landscape
      • 3.2.2.6. Legal landscape
    • 3.2.3. COVID-19 Impact Analysis

Chapter 4. Home Sleep Apnea Test Market: Regional Estimates & Trend Analysis, By Product, By Application, By End Use

  • 4.1. Regional Market Share Analysis, 2023 & 2030
  • 4.2. Regional Market Dashboard
  • 4.3. Global Regional Market Snapshot
  • 4.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 4.5. North America
    • 4.5.1. U.S.
      • 4.5.1.1. Key country dynamics
      • 4.5.1.2. Regulatory framework/ reimbursement structure
      • 4.5.1.3. Competitive scenario
      • 4.5.1.4. U.S. market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.5.2. Canada
      • 4.5.2.1. Key country dynamics
      • 4.5.2.2. Regulatory framework/ reimbursement structure
      • 4.5.2.3. Competitive scenario
      • 4.5.2.4. Canada market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.5.3. Mexico
      • 4.5.3.1. Key country dynamics
      • 4.5.3.2. Regulatory framework/ reimbursement structure
      • 4.5.3.3. Competitive scenario
      • 4.5.3.4. Canada market estimates and forecasts 2018 to 2030, (USD Billion)
  • 4.6. Europe
    • 4.6.1. UK
      • 4.6.1.1. Key country dynamics
      • 4.6.1.2. Regulatory framework/ reimbursement structure
      • 4.6.1.3. Competitive scenario
      • 4.6.1.4. UK market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.2. Germany
      • 4.6.2.1. Key country dynamics
      • 4.6.2.2. Regulatory framework/ reimbursement structure
      • 4.6.2.3. Competitive scenario
      • 4.6.2.4. Germany market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.3. France
      • 4.6.3.1. Key country dynamics
      • 4.6.3.2. Regulatory framework/ reimbursement structure
      • 4.6.3.3. Competitive scenario
      • 4.6.3.4. France market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.4. Italy
      • 4.6.4.1. Key country dynamics
      • 4.6.4.2. Regulatory framework/ reimbursement structure
      • 4.6.4.3. Competitive scenario
      • 4.6.4.4. Italy market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.5. Spain
      • 4.6.5.1. Key country dynamics
      • 4.6.5.2. Regulatory framework/ reimbursement structure
      • 4.6.5.3. Competitive scenario
      • 4.6.5.4. Spain market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.6. Norway
      • 4.6.6.1. Key country dynamics
      • 4.6.6.2. Regulatory framework/ reimbursement structure
      • 4.6.6.3. Competitive scenario
      • 4.6.6.4. Norway market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.7. Sweden
      • 4.6.7.1. Key country dynamics
      • 4.6.7.2. Regulatory framework/ reimbursement structure
      • 4.6.7.3. Competitive scenario
      • 4.6.7.4. Sweden market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.8. Denmark
      • 4.6.8.1. Key country dynamics
      • 4.6.8.2. Regulatory framework/ reimbursement structure
      • 4.6.8.3. Competitive scenario
      • 4.6.8.4. Denmark market estimates and forecasts 2018 to 2030, (USD Billion)
  • 4.7. Asia Pacific
    • 4.7.1. Japan
      • 4.7.1.1. Key country dynamics
      • 4.7.1.2. Regulatory framework/ reimbursement structure
      • 4.7.1.3. Competitive scenario
      • 4.7.1.4. Japan market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.7.2. China
      • 4.7.2.1. Key country dynamics
      • 4.7.2.2. Regulatory framework/ reimbursement structure
      • 4.7.2.3. Competitive scenario
      • 4.7.2.4. China market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.7.3. India
      • 4.7.3.1. Key country dynamics
      • 4.7.3.2. Regulatory framework/ reimbursement structure
      • 4.7.3.3. Competitive scenario
      • 4.7.3.4. India market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.7.4. Australia
      • 4.7.4.1. Key country dynamics
      • 4.7.4.2. Regulatory framework/ reimbursement structure
      • 4.7.4.3. Competitive scenario
      • 4.7.4.4. Australia market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.7.5. South Korea
      • 4.7.5.1. Key country dynamics
      • 4.7.5.2. Regulatory framework/ reimbursement structure
      • 4.7.5.3. Competitive scenario
      • 4.7.5.4. South Korea market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.7.6. Thailand
      • 4.7.6.1. Key country dynamics
      • 4.7.6.2. Regulatory framework/ reimbursement structure
      • 4.7.6.3. Competitive scenario
      • 4.7.6.4. Singapore market estimates and forecasts 2018 to 2030, (USD Billion)
  • 4.8. Latin America
    • 4.8.1. Brazil
      • 4.8.1.1. Key country dynamics
      • 4.8.1.2. Regulatory framework/ reimbursement structure
      • 4.8.1.3. Competitive scenario
      • 4.8.1.4. Brazil market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.8.2. Argentina
      • 4.8.2.1. Key country dynamics
      • 4.8.2.2. Regulatory framework/ reimbursement structure
      • 4.8.2.3. Competitive scenario
      • 4.8.2.4. Argentina market estimates and forecasts 2018 to 2030, (USD Billion)
  • 4.9. MEA
    • 4.9.1. South Africa
      • 4.9.1.1. Key country dynamics
      • 4.9.1.2. Regulatory framework/ reimbursement structure
      • 4.9.1.3. Competitive scenario
      • 4.9.1.4. South Africa market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.9.2. Saudi Arabia
      • 4.9.2.1. Key country dynamics
      • 4.9.2.2. Regulatory framework/ reimbursement structure
      • 4.9.2.3. Competitive scenario
      • 4.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.9.3. UAE
      • 4.9.3.1. Key country dynamics
      • 4.9.3.2. Regulatory framework/ reimbursement structure
      • 4.9.3.3. Competitive scenario
      • 4.9.3.4. UAE market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.9.4. Kuwait
      • 4.9.4.1. Key country dynamics
      • 4.9.4.2. Regulatory framework/ reimbursement structure
      • 4.9.4.3. Competitive scenario
      • 4.9.4.4. Kuwait market estimates and forecasts 2018 to 2030, (USD Billion)

Chapter 5. Competitive Landscape

  • 5.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 5.2. Company/Competition Categorization
  • 5.3. Key company market share/position analysis, 2023
  • 5.4. Company Profiles
    • 5.4.1. Resmed
      • 5.4.1.1. Company overview
      • 5.4.1.2. Financial performance
      • 5.4.1.3. Product benchmarking
      • 5.4.1.4. Strategic initiatives
    • 5.4.2. Itamar Medical Ltd a subsidiary of ZOLL Medical Corporation ( a ASAHI KASEI company)
      • 5.4.2.1. Company overview
      • 5.4.2.2. Financial performance
      • 5.4.2.3. Product benchmarking
      • 5.4.2.4. Strategic initiatives
    • 5.4.3. Cleveland Medical Devices Inc.
      • 5.4.3.1. Company overview
      • 5.4.3.2. Financial performance
      • 5.4.3.3. Product benchmarking
      • 5.4.3.4. Strategic initiatives
    • 5.4.4. Compumedics Limited
      • 5.4.4.1. Company overview
      • 5.4.4.2. Financial performance
      • 5.4.4.3. Product benchmarking
      • 5.4.4.4. Strategic initiatives
    • 5.4.5. Onera Technologies B.V.
      • 5.4.5.1. Company overview
      • 5.4.5.2. Financial performance
      • 5.4.5.3. Product benchmarking
      • 5.4.5.4. Strategic initiatives
    • 5.4.6. Sunrise
      • 5.4.6.1. Company overview
      • 5.4.6.2. Financial performance
      • 5.4.6.3. Product benchmarking
      • 5.4.6.4. Strategic initiatives
    • 5.4.7. Nox Medical
      • 5.4.7.1. Company overview
      • 5.4.7.2. Financial performance
      • 5.4.7.3. Product benchmarking
      • 5.4.7.4. Strategic initiatives
    • 5.4.8. Watermark Medical
      • 5.4.8.1. Company overview
      • 5.4.8.2. Financial performance
      • 5.4.8.3. Product benchmarking
      • 5.4.8.4. Strategic initiatives
    • 5.4.9. Bittium
      • 5.4.9.1. Company overview
      • 5.4.9.2. Financial performance
      • 5.4.9.3. Product benchmarking
      • 5.4.9.4. Strategic initiatives
    • 5.4.10. Cadwell Industries Inc.
      • 5.4.10.1. Company overview
      • 5.4.10.2. Financial performance
      • 5.4.10.3. Product benchmarking
      • 5.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Home Sleep Apnea Test Market, by region, (USD Billion) 2018 - 2030
  • Table 3 U.S. Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 4 Canada Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 5 Mexico Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 6 Europe Home Sleep Apnea Test Market, by region, (USD Billion) 2018 - 2030
  • Table 7 Germany Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 8 UK Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 9 France Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 10 Italy Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 11 Spain Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 12 Denmark Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 13 Sweden Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 14 Norway Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 15 Asia Pacific Home Sleep Apnea Test Market, by region, (USD Billion) 2018 - 2030
  • Table 16 China Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 17 Japan Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 18 India Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 19 South Korea Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 20 Australia Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 21 Thailand Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 22 Latin America Home Sleep Apnea Test Market, by region, (USD Billion) 2018 - 2030
  • Table 23 Brazil Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 24 Argentina Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 25 MEA Home Sleep Apnea Test Market, by region, (USD Billion) 2018 - 2030
  • Table 26 South Africa Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 27 Saudi Arabia Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 28 UAE Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 29 Kuwait Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Home Sleep Apnea Test Market outlook
  • Fig. 9 Home sleep apnea test competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Home Sleep Apnea Test Market driver impact
  • Fig. 15 Home Sleep Apnea Test Market restraint impact
  • Fig. 16 Home Sleep Apnea Test Market strategic initiatives analysis
  • Fig. 17 Global Home Sleep Apnea Test Market: Regional movement analysis
  • Fig. 18 Global Home Sleep Apnea Test Market: Regional outlook and key takeaways
  • Fig. 19 Global Home Sleep Apnea Test Market share and leading players
  • Fig. 20 North America market share and leading players
  • Fig. 21 Europe market share and leading players
  • Fig. 22 Asia Pacific market share and leading players
  • Fig. 23 Latin America market share and leading players
  • Fig. 24 Middle East & Africa market share and leading players
  • Fig. 25 North America: SWOT
  • Fig. 26 Europe SWOT
  • Fig. 27 Asia Pacific SWOT
  • Fig. 28 Latin America SWOT
  • Fig. 29 MEA SWOT
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 33 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 34 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 35 UK market estimates and forecasts, 2018 - 2030
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 37 France market estimates and forecasts, 2018 - 2030
  • Fig. 38 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 39 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 44 China market estimates and forecasts, 2018 - 2030
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 46 India market estimates and forecasts, 2018 - 2030
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 50 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 51 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 53 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 58 Market share of key market players- Home Sleep Apnea Test Market
  • Fig. 59 Key Company Categorization
  • Fig. 60 Company Market Share/Position Analysis, 2023
  • Fig. 61 Strategic Framework